SynthesisFrontiers in oncology2024

The efficacy and safety of immunotherapy as first-line treatment for extensive-stage small cell lung cancer: evaluating based on reconstructed individual patient data.

Shuang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.